A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer -- the fourth leading cause of cancer death -- every year. The blood biomarkers correctly detected pancreatic cancer in blood samples from patients at different stages of their disease.